How Trump's cannabis reclassification move could impact research
CBS America · Just In
CBS America
Just In
The Trump administration this week took steps to potentially reclassify cannabis as a less dangerous drug. Dr. Sue Sisley, an internal medicine clinician and principal investigator at the Scottsdale Research Institute in Arizona, joins CBS News to discuss.
Breakdown
- Trump signed order to move marijuana from Schedule I to Schedule III 15s
- Reclassification could enable more medical cannabis research 19s
- Dr. Sisley says Schedule I status impeded research for 50 years 54s
- Dr. Sisley calls for government funding to support new research 2m 19s
- Schedule III status could allow cannabis prescriptions in hospitals 2m 56s